Please try another search
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington’s disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Name | Age | Since | Title |
---|---|---|---|
Douglas Love | 54 | 2014 | CEO, President & Director |
Thomas G. Wiggans | 70 | 2017 | Independent Chairman |
Muneer Ahmad Satter | 61 | 2014 | Independent Director |
Bettina M. Cockroft | 55 | 2022 | Independent Director |
William H. Carson | 64 | 2021 | Independent Director |
Jung E. Choi | 54 | 2020 | Independent Director |
Stephen L. Hauser | - | - | Member of Scientific Advisory Board |
David M. Holtzman | - | - | Member of Scientific Advisory Board |
P. Hugh Willison | - | - | Member of Scientific Advisory Board |
Beth Stevens | - | - | Member of Scientific Advisory Board |
William D. Waddill | 67 | 2021 | Independent Director |
Thomas P. Maniatis | 81 | - | Member of Scientific Advisory Board |
Jeffrey Goldberg | - | - | Member of Scientific Advisory Board |
Ted Yednock | 66 | 2013 | Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review